drugset / Trial / NCT04953741

A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma

NCT04953741

Phase 4 Unknown 90 enrolled Xijing Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a 24-week, randomized, parallel group comparative effectiveness study to evaluate the risk of stepping down therapy for patients with well-controlled asthma treated with combination Inhaled corticosteroids (ICS) and Leukotriene receptor antagonist(LTRA).

Timeline

Start
2021-08-01
Primary completion
2022-08-01
Completion
2022-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 125 ug Inhaled